Experience with bortezomib for the treatment of patients with relapsed classical Hodgkin lymphoma.
Anas Younes, Barbara Pro, Luis FayadNo abstract text is available yet for this article.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.